Table 1. Clinical characteristics of screened patients on intensive care unit admission (n = 142).

Characteristics		N (%)
Age, years (mean ± SD)		65.9 ± 16.2
Age range
	<60 years	39 (27.5)
	60 - 79 years	73 (51.4)
	≥80 years	30 (21.1)
Sex
	Female : male	49 (34.5) : 93 (65.5)
Presence of comorbidities
	Diabetes mellitus	46 (32.4)
	Chronic heart disease	28 (19.7)
	Malignancy	25 (17.6)
	Chronic kidney disease	22 (15.5)
	Cerebrovascular disease	20 (14.1)
	Chronic liver disease	12 (8.5)
	COPD/bronchial asthma	11 (7.7)
	None	46 (32.4)
Diagnosis on ICU admission
	Seizure/stroke/other neurologic problems	38 (26.8)
	Pneumonia	26 (18.3)
	Malignancy	16 (11.3)
	Vascular problems	15 (10.6)
	Sepsis/diabetic ketoacidosis	12 (8.5)
	Gastrointestinal bleeding, obstruction or perforation	11 (7.7)
	Heart failure	6 (4.2)
	Fracture	6 (4.2)
	Renal transplantation/acute kidney injury	5 (3.5)
	Acute exacerbation of COPD or asthma/other airway problems	4 (2.8)
	Cardiac arrest	3 (2.1)
Indication for ICU admission
	Postoperative care	74 (52.1)
	Mechanical ventilation	28 (19.7)
	Close monitoring	24 (16.9)
	Conventional renal replacement therapy	9 (6.3)
	Post-CPR care	7 (4.9)
Intubated state at SARS-CoV-2 screening		81 (57.0)
Chest abnormality on ICU admission
	No active lung lesion	72 (50.7)
	Patchy or reticular opacities	31 (21.8)
	Pulmonary edema	16 (11.3)
	Granulomas/nodules/atelectasis	12 (8.5)
	Pleural effusion	11 (7.7)
Laboratory abnormalities
	Leukocytosis	87 (61.3)
	Thrombocytopenia	24 (16.9)
	Elevation of C-reactive protein level	93 (65.5)

Data are presented as n (%), if not otherwise specified.

SD, standard deviation; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; CPR, cardiopulmonary resuscitation; SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2.